Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Zhejiang Shenghua Biok Biology Co Ltd signs letter of intent to sell 85 pct stake in subsidiary


Thursday, 2 Jan 2014 07:00pm EST 

Zhejiang Shenghua Biok Biology Co Ltd:Says it has signed a letter of intent to sell a 85 pct stake in a Zhejiang-based subsidiary, which is engaged in production and sales of muriatic acid, methyl chloride and phosphite, to a Guangdong-based technology company. 

Company Quote

6.15
0.15 +2.50%
16 Apr 2014